This is the first in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR, and what the Therapeutic Goods Administration (TGA) is doing to streamline the transition process.
Presenters
Dr Amanda Craig, Director, Devices Post-Market Reforms and Reviews, TGA
Dr Xin-Lin Goh, Director, Devices Applications, TGA
